Feb 19, 2026
BioXcel Therapeutics to Host Virtual Roundtable Featuring Leading Medical Experts Addressing Latest Developments in Treatment of Acute Agitation in Alzheimer’s DementiaVIEW RELEASE
Feb 12, 2026
BioXcel Therapeutics Completes Market Opportunity Assessment and Advances Commercialization Plans for IGALMI® in the At-Home SettingVIEW RELEASE
Jan 20, 2026
BioXcel Therapeutics Submits Supplemental New Drug Application to U.S. Food and Drug Administration for IGALMI® Label Expansion in the At-Home SettingVIEW RELEASE
Stock Information
BioXcel Therapeutics, Inc.
Feb 19, 2026 04:00 PM
MARKET/SYMBOL
Nasdaq:
BTAI
PRICE
1.62
CHANGE
0.04 (2.53%)
